Literature DB >> 24403219

An epidemiologic internet survey of fibromyalgia and chronic pain in Japan.

Ikuro Nakamura1, Kenya Nishioka, Chie Usui, Kenichi Osada, Hisao Ichibayashi, Mitsuhiro Ishida, Dennis C Turk, Yoshifuji Matsumoto, Kusuki Nishioka.   

Abstract

OBJECTIVE: To determine the epidemiologic features and symptom characteristics of fibromyalgia (FM) in Japan, and compare them with those for other chronic pain (CP) diagnoses.
METHODS: An internet survey was conducted in June and July 2011. The questionnaire consisted of 111 questions, including assessments of the Japanese version of the 2010 American College of Rheumatology preliminary diagnostic criteria for FM, the Japanese Fibromyalgia Impact Questionnaire, and additional questions regarding pain and lifestyle.
RESULTS: The questionnaire was completed by 20,407 male and female respondents in all prefectures of Japan. Of the survey population, 2,524 respondents (12.4%) reported symptoms consistent with CP; of these, 425 (2.1%) reported symptoms consistent with FM. Among respondents with FM and CP, 61% and 53%, respectively, were women. Pain severity and Widespread Pain Index scores were significantly higher in respondents meeting the diagnostic criteria for FM than in those meeting the criteria for CP. In terms of symptom severity scores, the proportions of respondents reporting the 3 major symptoms as "highly applicable" and greater numbers of 41 somatic symptoms were higher among respondents with FM than among those with CP. The incidence of FM in the present survey was similar to that reported (1.7%) in a study of FM in Japan in 2003, despite the use of the newer, easier to use 2010 diagnostic criteria.
CONCLUSION: Because FM usually presents with more severe and more widely distributed pain, as well as more nonpainful symptoms than CP, our results suggest that FM is a different clinical phenotype of CP.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24403219     DOI: 10.1002/acr.22277

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  21 in total

Review 1.  Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Authors:  Brian Walitt; Gerard Urrútia; María Betina Nishishinya; Sarah E Cantrell; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

2.  Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients.

Authors:  Winfried Häuser; Eva-Maria Hoffmann; Frederick Wolfe; Angus B Worthing; Neil Stahl; Russell Rothenberg; Brian Walitt
Journal:  Clin Exp Rheumatol       Date:  2015-03-18       Impact factor: 4.473

3.  Effects of Acupuncture Therapy on Drug-Resistant Fibromyalgia: An Exploratory Single-Arm Nonrandomized Trial.

Authors:  Yoichi Minakawa; Shingo Saito; Yoshifuji Matsumoto; Hiroshi Oka; Kenji Miki; Masao Yukioka; Kazunori Itoh
Journal:  Med Acupunct       Date:  2022-06-16

4.  Understanding the Needs and Priorities of People Living with Persistent Pain and Long-Term Musculoskeletal Conditions during the COVID-19 Pandemic-A Public Involvement Project.

Authors:  Sally Fowler Davis; Helen Humphreys; Tom Maden-Wilkinson; Sarah Withers; Anna Lowe; Robert J Copeland
Journal:  Healthcare (Basel)       Date:  2022-06-17

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

6.  Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample.

Authors:  Ying Zhang; Dongfeng Liang; Ronghuan Jiang; Xiaojian Ji; Yiwen Wang; Jian Zhu; Jianglin Zhang; Feng Huang
Journal:  Clin Rheumatol       Date:  2017-10-13       Impact factor: 2.980

7.  Weather sensitivity associated with quality of life in patients with fibromyalgia.

Authors:  Kazuhiro Hayashi; Kenji Miki; Noriyuki Hayashi; Ryota Hashimoto; Masao Yukioka
Journal:  BMC Rheumatol       Date:  2021-05-10

8.  A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.

Authors:  Masato Murakami; Kenichi Osada; Hiromichi Mizuno; Toshimitsu Ochiai; Levent Alev; Kusuki Nishioka
Journal:  Arthritis Res Ther       Date:  2015-08-22       Impact factor: 5.156

Review 9.  Aerobic exercise training for adults with fibromyalgia.

Authors:  Julia Bidonde; Angela J Busch; Candice L Schachter; Tom J Overend; Soo Y Kim; Suelen M Góes; Catherine Boden; Heather Ja Foulds
Journal:  Cochrane Database Syst Rev       Date:  2017-06-21

10.  Pain-QuILT: clinical feasibility of a web-based visual pain assessment tool in adults with chronic pain.

Authors:  Chitra Lalloo; Dinesh Kumbhare; Jennifer N Stinson; James L Henry
Journal:  J Med Internet Res       Date:  2014-05-12       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.